AMCP responded in a letter to the editor of Health Affairs stressing that managed care tools work to address the misalignment between drug prices and clinical value. In her latest blog post, AMCP CEO Susan Cantrell dives deeper into the reason behind the response and how it supported the need for value-based pricing.
Nearly 40 experts representing payers, pharmacy benefit managers, integrated delivery systems, patient advocates, academicians, and other key stakeholders in the managed care setting convened for AMCP’s Partnership Forum Addressing Evidence Gaps in the Expedited Review Process: Payer Perspectives.